Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Lee

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Cancers|May 11, 2024
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in GlioblastomaDanielle Maeser, Robert F Gruener, Robert Galvin, et al.
Age and Ageing|May 16, 2021
Optimal management of older people with frailty non-weight bearing after lower limb fracture: a scoping reviewSaleh Aloraibi, Vicky Booth, Katie Robinson, et al.
BMC Cancer|January 23, 2020
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer CentreChris Twelves, Sue Cheeseman, Will Sopwith, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2025
Does the availability of non-cross matched blood in the trauma bay effect the outcome of trauma patients? A retrospective study from a level-II trauma centerDaniella Moshe, Noa Dina Rose, Asher Winder, et al.
Journal of Medical Economics|June 6, 2022
Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United StatesMaria Polyzoi, Hera Sandhu, Johan Maervoet, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2023
Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysisKenneth O'Byrne, Evan Popoff, Firas Badin, et al.
Age and Ageing|December 12, 2025
Effects of supplemental protein in older people: an overview of meta-analysesAkanu Abass Obasi, Adam Lee Gordon, Kenneth Smith, et al.
Age and Ageing|August 3, 2025
New horizons in improving research capacity in English care homes for older adultsElisa Ruiz-Burga, Paul Flowers, Zoe Fry, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Simplicity: web-based visualization and analysis of high-throughput cancer cell line screensAlexander L Ling, Weijie Zhang, Adam Lee, et al.
The Journal of the American Academy of Orthopaedic Surgeons|January 24, 2025
Infection Rate and Antibiotic Administration for Urban Low-Energy Gunshot Wounds at an Academic Level 1 Trauma CenterHayden P Baker, Jason Dickherber, Andrew J Straszewski, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Cancers|May 11, 2024
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in GlioblastomaDanielle Maeser, Robert F Gruener, Robert Galvin, et al.
Age and Ageing|May 16, 2021
Optimal management of older people with frailty non-weight bearing after lower limb fracture: a scoping reviewSaleh Aloraibi, Vicky Booth, Katie Robinson, et al.
BMC Cancer|January 23, 2020
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer CentreChris Twelves, Sue Cheeseman, Will Sopwith, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2025
Does the availability of non-cross matched blood in the trauma bay effect the outcome of trauma patients? A retrospective study from a level-II trauma centerDaniella Moshe, Noa Dina Rose, Asher Winder, et al.
Journal of Medical Economics|June 6, 2022
Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United StatesMaria Polyzoi, Hera Sandhu, Johan Maervoet, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2023
Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysisKenneth O'Byrne, Evan Popoff, Firas Badin, et al.
Age and Ageing|December 12, 2025
Effects of supplemental protein in older people: an overview of meta-analysesAkanu Abass Obasi, Adam Lee Gordon, Kenneth Smith, et al.
Age and Ageing|August 3, 2025
New horizons in improving research capacity in English care homes for older adultsElisa Ruiz-Burga, Paul Flowers, Zoe Fry, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Simplicity: web-based visualization and analysis of high-throughput cancer cell line screensAlexander L Ling, Weijie Zhang, Adam Lee, et al.
The Journal of the American Academy of Orthopaedic Surgeons|January 24, 2025
Infection Rate and Antibiotic Administration for Urban Low-Energy Gunshot Wounds at an Academic Level 1 Trauma CenterHayden P Baker, Jason Dickherber, Andrew J Straszewski, et al.
Pageof 20